• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可转移的β-内酰胺酶。粪肠球菌体外青霉素耐药的一种新机制。

Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.

作者信息

Murray B E, Mederski-Samaroj B

出版信息

J Clin Invest. 1983 Sep;72(3):1168-71. doi: 10.1172/JCI111042.

DOI:10.1172/JCI111042
PMID:6411768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1129285/
Abstract

Although enterococci are relatively resistant to penicillin, the mechanism of resistance is largely unknown and enzymatic inactivation does not play a role. In this study, an isolate of Streptococcus faecalis was found to have beta lactamase activity resulting in complete inactivation of penicillin. With a high inoculum, this strain was resistant to greater than 1,000 micrograms/ml of penicillin. Penicillin resistance and beta lactamase activity were transferred by conjugation at a high frequency to an enterococcal laboratory recipient strain together with two plasmids of molecular size 34 X 10(6) and 56 X 10(6), thus demonstrating the emergence of plasmid-mediated penicillin resistance in the genus Streptococcus.

摘要

尽管肠球菌对青霉素相对耐药,但其耐药机制很大程度上尚不清楚,且酶失活不起作用。在本研究中,发现一株粪链球菌具有β-内酰胺酶活性,导致青霉素完全失活。在高接种量时,该菌株对大于1000微克/毫升的青霉素耐药。青霉素耐药性和β-内酰胺酶活性通过接合高频转移至一株肠球菌实验室受体菌株,同时伴有两个分子大小分别为34×10⁶和56×10⁶的质粒,从而证明在链球菌属中出现了质粒介导的青霉素耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fec/1129285/7c26c0443a30/jcinvest00769-0429-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fec/1129285/7c26c0443a30/jcinvest00769-0429-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fec/1129285/7c26c0443a30/jcinvest00769-0429-a.jpg

相似文献

1
Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.可转移的β-内酰胺酶。粪肠球菌体外青霉素耐药的一种新机制。
J Clin Invest. 1983 Sep;72(3):1168-71. doi: 10.1172/JCI111042.
2
In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin.来自粪肠球菌的质粒介导青霉素酶的体外研究表明其起源于葡萄球菌。
J Clin Invest. 1986 Jan;77(1):289-93. doi: 10.1172/JCI112289.
3
Characterization and comparison of two penicillinase-producing strains of Streptococcus (Enterococcus) faecalis.两种产青霉素酶粪肠球菌(肠球菌)菌株的特性鉴定与比较。
Antimicrob Agents Chemother. 1988 Jan;32(1):122-4. doi: 10.1128/AAC.32.1.122.
4
[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].[作为尿路病原体的肠球菌。分离频率及对抗菌药物的敏感性]
Ann Urol (Paris). 1998;32(1):15-9.
5
Characterization, antibiotic susceptibility pattern and detection of beta-lactamases in Enterococci.肠球菌的特征、抗生素敏感性模式及β-内酰胺酶检测
Indian J Pathol Microbiol. 2002 Jan;45(1):79-82.
6
[Beta-lactamase activity of bacteria of the genus Proteus].[变形杆菌属细菌的β-内酰胺酶活性]
Antibiotiki. 1978 Mar;23(3):223-7.
7
Comparison of two beta-lactamase-producing strains of Streptococcus faecalis.两种产β-内酰胺酶粪肠球菌菌株的比较。
Antimicrob Agents Chemother. 1986 Dec;30(6):861-4. doi: 10.1128/AAC.30.6.861.
8
Beta-lactamase-producing enterococci.
Dev Biol Stand. 1995;85:107-14.
9
[Actual resistance of Staphylococcus aureus: beta-Lactamase production and susceptibility to various penicillins and erythromycin (author's transl)].金黄色葡萄球菌的实际耐药性:β-内酰胺酶的产生以及对各种青霉素和红霉素的敏感性(作者译)
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol. 1982 Apr;251(4):479-86.
10
Newer penicillins and beta-lactamase inhibitors.新型青霉素和β-内酰胺酶抑制剂。
Infect Dis Clin North Am. 1989 Sep;3(3):571-94.

引用本文的文献

1
Extended-spectrum beta-lactamases: definition, history, an update on their genetic environment and detection methods.超广谱β-内酰胺酶:定义、历史、其基因环境及检测方法的最新进展
J Med Microbiol. 2025 Jun;74(6). doi: 10.1099/jmm.0.002033.
2
Non- non- enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance.非肠球菌:临床特征、毒力因子和抗菌药物耐药性综述。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0012123. doi: 10.1128/cmr.00121-23. Epub 2024 Mar 11.
3
Successful use of a phage endolysin for treatment of chronic pelvic pain syndrome/chronic bacterial prostatitis.

本文引用的文献

1
Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall.肠球菌杀伤缺陷:作用于细胞壁的抗菌药物的共同特性。
Antimicrob Agents Chemother. 1980 Jun;17(6):965-8. doi: 10.1128/AAC.17.6.965.
2
Binding of beta-lactam antibiotics to penicillin-binding proteins of Staphylococcus aureus and Streptococcus faecalis: relation to antibacterial activity.β-内酰胺类抗生素与金黄色葡萄球菌和粪肠球菌青霉素结合蛋白的结合:与抗菌活性的关系。
Antimicrob Agents Chemother. 1980 Nov;18(5):834-6. doi: 10.1128/AAC.18.5.834.
3
Transferability of macrolide, lincomycin, and streptogramin resistances between group A, B, and D streptococci, Streptococcus pneumoniae, and Staphylococcus aureus.
噬菌体溶菌酶成功用于治疗慢性盆腔疼痛综合征/慢性细菌性前列腺炎。
Front Med (Lausanne). 2023 Aug 15;10:1238147. doi: 10.3389/fmed.2023.1238147. eCollection 2023.
4
Virulence and Resistant Traits Associated with Its Permanence in the Hospital Environment.与其在医院环境中持续存在相关的毒力和耐药特性。
Antibiotics (Basel). 2022 Jun 26;11(7):857. doi: 10.3390/antibiotics11070857.
5
Spatial segregation and cooperation in radially expanding microbial colonies under antibiotic stress.抗生素胁迫下径向扩张微生物菌落的空间隔离与合作。
ISME J. 2021 Oct;15(10):3019-3033. doi: 10.1038/s41396-021-00982-2. Epub 2021 May 5.
6
Exploring the Therapeutic Potenital of the Leaderless Enterocins K1 and EJ97 in the Treatment of Vancomycin-Resistant Enterococcal Infection.探索无乳链球菌肠毒素K1和EJ97在治疗耐万古霉素肠球菌感染中的治疗潜力。
Front Microbiol. 2021 Feb 17;12:649339. doi: 10.3389/fmicb.2021.649339. eCollection 2021.
7
Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.应对产β-内酰胺酶 ESKAPE 病原体的新兴策略。
Int J Mol Sci. 2020 Nov 12;21(22):8527. doi: 10.3390/ijms21228527.
8
Delayed antibiotic exposure induces population collapse in enterococcal communities with drug-resistant subpopulations.延迟抗生素暴露会导致具有耐药亚群的肠球菌群落的种群崩溃。
Elife. 2020 Mar 24;9:e52813. doi: 10.7554/eLife.52813.
9
Epidemiology of β-Lactamase-Producing Pathogens.产β-内酰胺酶病原体的流行病学。
Clin Microbiol Rev. 2020 Feb 26;33(2). doi: 10.1128/CMR.00047-19. Print 2020 Mar 18.
10
Detection of β-Lactamase-Producing and Vancomycin-Resistant Isolates in Human Invasive Infections in the Public Hospital of Tandil, Argentina.在阿根廷坦迪尔公立医院的人类侵袭性感染中检测产β-内酰胺酶和耐万古霉素的分离株。
Pathogens. 2020 Feb 20;9(2):142. doi: 10.3390/pathogens9020142.
大环内酯类、林可霉素类及链阳菌素类耐药性在A组、B组和D组链球菌、肺炎链球菌及金黄色葡萄球菌之间的可转移性。
J Bacteriol. 1980 May;142(2):407-13. doi: 10.1128/jb.142.2.407-413.1980.
4
High-level resistance to gentamicin in clinical isolates of enterococci.肠球菌临床分离株对庆大霉素的高水平耐药性。
J Infect Dis. 1983 Apr;147(4):751-7. doi: 10.1093/infdis/147.4.751.
5
Plasmids, drug resistance, and gene transfer in the genus Streptococcus.链球菌属中的质粒、耐药性与基因转移
Microbiol Rev. 1981 Sep;45(3):409-36. doi: 10.1128/mr.45.3.409-436.1981.
6
Synergy of penicillin and gentamicin against Enterococci.青霉素与庆大霉素对肠球菌的协同作用。
J Infect Dis. 1971 Dec;124 Suppl:S207-9. doi: 10.1093/infdis/124.supplement_1.s207.
7
Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.D组链球菌(肠球菌)对21种抗生素的体外敏感性,特别提及种间差异。
Am J Med Sci. 1969 Dec;258(6):416-30. doi: 10.1097/00000441-196912000-00006.
8
Recognition of group D streptococcal species of human origin by biochemical and physiological tests.通过生化和生理学测试识别源自人类的D组链球菌菌种。
Appl Microbiol. 1972 Jun;23(6):1131-9. doi: 10.1128/am.23.6.1131-1139.1972.
9
I. Prevalence of extrachromosomal drug resistance. Changes in asusceptibility of selected pathogenic bacteria to widely used antibiotics.
Ann N Y Acad Sci. 1971 Jun 11;182:5-20. doi: 10.1111/j.1749-6632.1971.tb30639.x.
10
Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes.粪肠球菌发酵变种中质粒介导的多重抗生素抗性的接合转移
J Bacteriol. 1974 Feb;117(2):360-72. doi: 10.1128/jb.117.2.360-372.1974.